|
|
||||||||||
|
J Am Coll Cardiol, 2007; 50:309-315, doi:10.1016/j.jacc.2007.01.098
(Published online 6 July 2007). © 2007 by the American College of Cardiology Foundation |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


* Department of Cardiology and the Center for Medical Education
Department of Research and Evaluation, Kaiser Permanente Medical Center (KPMC), Pasadena, California
Manuscript received November 7, 2006; revised manuscript received January 8, 2007, accepted January 17, 2007.
* Reprint requests and correspondence: Dr. Albert Yuh-Jer Shen, Department of Cardiology, 1526 Edgemont Street, 2nd Floor, Kaiser Foundation Hospitals, Los Angeles, California 90027 (Email: albert.y-j.shen{at}kp.org).
Objectives: This study was designed to study racial/ethnic differences in the risk for intracranial hemorrhage (ICH) and the effect of warfarin on ICH risk among patients with atrial fibrillation (AF).
Background: Nonwhites are at greater risk for ICH than whites in the general population. Whether this applies to patients with AF and whether warfarin therapy is associated with comparable risk of ICH in nonwhites are unknown.
Methods: We retrospectively identified a multiethnic stroke-free cohort hospitalized with nonrheumatic AF. Warfarin use and anticoagulation intensity were assessed by searching pharmacy and laboratory records. Crude ICH event rates were calculated by Poisson regression. Cox proportional hazard models were constructed to assess the independent effect of race/ethnicity on ICH after adjusting for age, gender, hypertension, diabetes, heart failure, and warfarin exposure.
Results: Between 1995 and 2000, we identified 18,867 qualifying AF hospitalizations (78.5% white, 8% black, 9.5% Hispanic, and 3.9% Asian) and 173 qualifying ICH events over 3.3 years follow-up. Achieved anticoagulation intensity was lower among blacks but not different between the other groups. Warfarin was associated with increased ICH risk in all races, but the magnitude of risk was greater among nonwhites. There were no gender differences. The hazard ratio for ICH with whites as referent was 4.06 for Asians (95% confidence interval [CI] 2.47 to 6.65), 2.06 for Hispanics (95% CI 1.31 to 3.24), and 2.04 (95% CI 1.25 to 3.35) for blacks.
Conclusions: Nonwhites with AF were at greater risk for warfarin-related ICH. Blacks, Hispanics, and Asians were at successively greater ICH risk than whites.
| |||||||||
Related Article
J. Am. Coll. Cardiol. 2007 50: 316-318.
This article has been cited by other articles:
![]() |
A. Y.-J. Shen, J. F. Yao, S. S. Brar, M. B. Jorgensen, X. Wang, and W. Chen Racial/Ethnic Differences in Ischemic Stroke Rates and the Efficacy of Warfarin Among Patients With Atrial Fibrillation Stroke, October 1, 2008; 39(10): 2736 - 2743. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Jolobe Risk factors for anticoagulation-related bleeding complications QJM, May 1, 2008; 101(5): 419 - 419. [Full Text] [PDF] |
||||
![]() |
R. H. Falk Ethnic Disparity in Intracranial Hemorrhage Among Anticoagulated Patients With Atrial Fibrillation: An Answer in Search of a Question? J. Am. Coll. Cardiol., July 24, 2007; 50(4): 316 - 318. [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |